Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

10.75p
   
  • Change Today:
      0.75p
  • 52 Week High: 17.60p
  • 52 Week Low: 1.09p
  • Currency: UK Pounds
  • Shares Issued: 502.72m
  • Volume: 2,667,582
  • Market Cap: £54.04m
  • RiskGrade: 328
  • Beta: 0.72

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Timothy Paul McCarthy 1,488,462 £160,010
Lisa Baderoon 583,963 £62,776
Tim Franklin 525,000 £56,438

Major Shareholders

Notifier** Holding Value*
Lanstead Capital LP 25,108,044 £2,699,115
Luca & Associates AG 22,000,000 £2,365,000
Invesco Ltd 17,872,341 £1,921,277
Aviva Investors Global 11,285,180 £1,213,157
Alora Pharmaceuticals LLC 10,909,091 £1,172,727
M&G Investments 7,600,000 £817,000
Prudential plc 7,600,000 £817,000
Capital Income Builder 4,870,367 £523,564
Dr R Zimmer 4,551,553 £489,292
Odey Asset Management 3,433,319 £369,082
Rhone Trustees (Switzerland) SA 3,386,000 £363,995
Pictet Overseas Trust Corporation Limited 3,287,500 £353,406

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 10.75p
Change Today 0.75p
% Change 7.50 %
52 Week High 17.60p
52 Week Low 1.09p
Volume 2,667,582
Shares Issued 502.72m
Market Cap £54.04m
Beta 0.72
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average
21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average
Price Trend
67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average
40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 05-Nov-2025

Time Volume / Share Price
15:27 137,160 @ 10.94p
16:30 276 @ 11.10p
16:35 1,460 @ 10.75p
16:35 760 @ 10.75p
16:35 219 @ 10.75p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page